PeptidePedia The community reference

Contributions of GIP_Genoveva

User contributions·27 logged edits·page 1 of 1

Contributions by GIP_Genoveva, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 8,033 edits includes activity predating the current log.

  1. 05:33, 18 Jul 2026 (diff | hist) Mass spectrometry 5,612 ±0 add the peptide-content point: area percent alone cannot give a mass
  2. 06:41, 12 Jun 2026 (diff | hist) Incretin effect 7,358 ±0 give the magnitude of the incretin effect as a percentage of the insulin response
  3. 09:20, 11 Jun 2026 (diff | hist) Janoshik Analytical 5,235 ±0 add the cross-link to the traceability article
  4. 10:28, 21 May 2026 (diff | hist) Repackaging 4,759 ±0 state that overlay gas is used and name it
  5. 12:10, 20 May 2026 (diff | hist) GLP-1 receptor 7,570 ±0 expand §Structure and ligand engagement
  6. 08:55, 4 Apr 2026 (diff | hist) Talk:Dual incretin agonist 822 +79 /* The GIP agonist-versus-antagonist problem */ reply
  7. 09:20, 3 Apr 2026 (diff | hist) Talk:Dual incretin agonist 400 +210 /* The GIP agonist-versus-antagonist problem */ new section
  8. 06:21, 30 Mar 2026 (diff | hist) Albumin binding half-life extension 6,399 ±0 m expand §Design variables
  9. 21:46, 11 Mar 2026 (diff | hist) PolyPeptide Group (Hangzhou) 17,868 +220 m ce per PP:MOS
  10. 13:13, 4 Mar 2026 (diff | hist) Albumin binding half-life extension 6,399 ±0 distinguish the active and total forms of the hormone throughout
  11. 06:52, 21 Feb 2026 (diff | hist) Enteroendocrine L cell 5,083 ±0 the half-life given was for the intact peptide; label it
  12. 10:15, 9 Feb 2026 (diff | hist) Gastric emptying 5,565 ±0 add category for receptor pharmacology
  13. 22:23, 29 Jan 2026 (diff | hist) Prescribing information 4,506 ±0 de-orphan
  14. 08:12, 10 Jan 2026 (diff | hist) Talk:Glucagon 1,096 +60 /* GIP and glucagon secretion — contradiction with the GIP article? */ reply
  15. 09:33, 9 Jan 2026 (diff | hist) Talk:Glucagon 674 +190 /* GIP and glucagon secretion — contradiction with the GIP article? */ new section
  16. 14:10, 23 Nov 2025 (diff | hist) Haemoglobin A1c 4,243 ±0 add category for laboratory medicine
  17. 19:17, 21 Nov 2025 (diff | hist) Gastric emptying 5,565 ±0 m rm the sentence implying the hormone is a drug
  18. 07:44, 27 Aug 2025 (diff | hist) Albumin binding half-life extension 6,399 +378 m add the citation for the co-secretion finding
  19. 10:38, 3 Jul 2025 (diff | hist) SinoPep 3,724 ±0 m expand §Product range
  20. 16:01, 31 May 2025 (diff | hist) Aspiration risk under anaesthesia 3,911 ±0 add the note that titration exists partly to manage these effects
  21. 06:12, 3 May 2025 (diff | hist) Proglucagon 5,743 ±0 m add the postprandial time course with its units
  22. 20:46, 28 Apr 2025 (diff | hist) Receptor bias 3,536 ±0 unpipe a link that did not need piping
  23. 13:56, 25 Mar 2025 (diff | hist) Glucagon-like peptide-1 10,239 ±0 rm the causal claim about appetite — the cited work is associative
  24. 18:12, 3 Dec 2024 (diff | hist) Dipeptidyl peptidase-4 4,336 +168 m convert the receptor-distribution list to a table
  25. 04:49, 6 Oct 2024 (diff | hist) GLP-1 receptor 4,864 +997 typo
  26. 15:27, 25 Sep 2024 (diff | hist) Fasting insulin 1,662 +601 state whether the figure is a mean or a median
  27. 03:48, 4 Jul 2024 (diff | hist) Glucose-dependent insulinotropic polypeptide 2,551 +793 the half-life given was for the intact peptide; label it